Agfa sees increased sales in 1998

Article

Bayer’s Agfa division reported its fiscal 1998 results last month. Agfa saw sales rise by 5% to DM 8.5 billion ($4.7 billion), as compared with DM 8.1 billion ($4.5 billion) in 1997. Its operating profit declined by 12.9% to $2.7 million, which the

Bayer’s Agfa division reported its fiscal 1998 results last month. Agfa saw sales rise by 5% to DM 8.5 billion ($4.7 billion), as compared with DM 8.1 billion ($4.5 billion) in 1997. Its operating profit declined by 12.9% to $2.7 million, which the company attributed to the Asian financial crisis.

Sales in Agfa’s technical imaging systems division climbed 8% in 1998 as compared with 1997, from $993 million to $1 billion. The group’s medical business unit contributed about three-quarters of the division’s sales, Bayer said. In January, Agfa moved to acquire Sterling Diagnostic Imaging (SCAN 1/20/99), and the purchase should be completed this spring, according to the company.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.